|
|
Association between Docosahexaenoic Acid Intensity and the Presence of Diabetic Retinopathy |
Jingjing Zuo1 , Yuan Lan2 , Xiangqing Hou3 , Jushuang Li3 , Tao Wang3 , Chengnan Guo3 , Fang Peng3 , Honglin Hu4 , Chao Zheng5 , Guangyun Mao1, 3 |
1 Eye Hospital, School of Ophthalmology & Optometry, Wenzhou Medical University, Wenzhou 325027, China 2 Department of Ophthalmology, Pingxiang People's Hospital, Pingxiang 337000, China 3 Department of Preventive Medicine, School of Public Health & Management, Wenzhou Medical University, Wenzhou 325035, China 4 Department of Endocrinology, the First Affiliated Hospital of Anhui Medical University, Hefei 230031, China 5 Department of Endocrinology, the Second Affiliated Hospital of Wenzhou Medical University, Wenzhou 325027, China |
|
|
Abstract Objective: To investigate the association of docosahexaenoic acid (DHA) with the presence of diabetic retinopathy (DR). Methods: This was a multiple-center, hospital-based, case-control study. A total of 197 type 2 diabetes mellitus (T2D) patients aged no less than 35 years old were enrolled from two affiliated hospitals of Wenzhou Medical University and Anhui Medical University. Depending on the fundus photos, they were classified into T2D (controls) and T2D combined with DR (cases). Based on propensity score matching, at a ratio of 1:1, by age, sex, body mass index and glycated hemoglobin, 69 pairs of cases and controls were included in the final data analysis. The intensity of DHA was determined using the ultraperformance liquid chromatography-electrospray ionization-tandem mass spectrometry (UPLC-ESI-MS/ MS) system. Multiple locally weighted regression and conditional logistic regression models were applied to comprehensively assess the association between DHA and the presence of DR. In addition, the results of a heterogeneity test and the interaction of DHA and the subgroups were displayed by a forest map. Results: A total of 69 pairs of cases and controls were included in the present study. The intensity of DHA in the cases was significantly lower than that of the controls (t=3.68, P=0.001). After adjusting for potential confounding factors including age, triglyceride, hypertension and diabetes duration, the prevalence of DR was significantly reduced by 53% (odds ratio: 0.47; 95% confidence interval: 0.30, 0.73) with a per interquartile range elevation of DHA. As is shown in the forest map, associations of DHA with the odds of DR were consistent in each subgroup and no interaction effects between the subgroups and DHA were observed. Conclusions: DHA is an independent protective factor of DR and significantly associated with its initiation and progression. Our findings emphasize the clinical and public policy relevance of early screening for DR as well as its secondary prevention, which perhaps should be confirmed by additional large, longitudinal studies.
|
Received: 17 October 2019
|
Fund:Zhejiang Basic Public Welfare Research Project (LGF19H260011); Wenzhou Basic Public Welfare Research Project (Y20180201); Initial Scientific Research Fund of the Eye Hospital of Wenzhou Medical University (KYQD170301); Academician's Science and Technology Innovation Program in Zhejiang Province (2018R413182). |
Corresponding Authors:
Guangyun Mao, Eye Hospital, School of Ophthalmology & Optometry, Wenzhou Medical University, Wenzhou 325027, China; Department of Preventive Medicine, School of Public Health & Management, Wenzhou Medical University, Wenzhou 325035, China (Email: mgy@wmu.edu.cn)
|
|
|
|
[1] |
Cheung N, Mitchell P, Wong TY. Diabetic retinopathy. The Lancet, 2010, 376(9735): 124-136. DOI: 10.1016/s0140- 6736(09)62124-3.
|
[2] |
Wong TY, Cheung CM, Larsen M, et al. Diabetic retinopathy. Nat Rev Dis Primers, 2016, 2(1): 16012. DOI: 10.1038/nrdp. 2016.12.
|
[3] |
Sabanayagam C, Banu R, Chee ML, et al. Incidence and progression of diabetic retinopathy: A systematic review. Lancet Diabetes Endocrinol, 2019, 7 (2): 140-149. DOI: 10.1016/ S2213-8587(18)30128-1.
|
[4] |
Brussels BIDF. International Diabetes Federation. IDF Diabetes Atlas, 8th edn. 2017.
|
[5] |
Song P, Yu J, Chan KY, et al. Prevalence, risk factors and burden of diabetic retinopathy in China: A systematic review and metaanalysis. J Glob Health, 2018, 8(1): 010803. DOI: 10.7189/jogh. 08.010803.
|
[6] |
Eynard AR, Repossi G. Role of omega-3 polyunsaturated fatty acids in diabetic retinopathy: A morphological and metabolically cross talk among blood retina barriers damage, autoimmunity and chronic inflammation. Lipids Health Dis, 2019, 18(1): 114. DOI: 10.1186/s12944-019-1049-9.
|
[7] |
SanGiovanni JP, Chew EY. The role of omega-3 long-chain polyunsaturated fatty acids in health and disease of the retina. Prog Retin Eye Res, 2005, 24(1): 87-138. DOI: 10.1016/ j.preteyeres.2004.06.002.
|
[8] |
中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2017年版). 中华糖尿病杂志, 2018, 10(1): 4-67. DOI: 10.3760/cma. j.issn.1674-5809.2018.01.003.
|
[9] |
中华医学会眼科学分会眼底病学组, 中国医师协会眼科医师分会眼底病专业委员会. 我国糖尿病视网膜病变筛查的图像采集及阅片指南(2017年). 中华眼科杂志, 2017, 53(12): 890- 896. DOI: 10.3760/cma.j.issn.0412-4081.2017.12.003.
|
[10] |
Zhu G, Wang S, Huang Z, et al. Rewiring of the fruit metabolome in tomato breeding. Cell, 2018, 172(1-2): 249-261 e212. DOI: 10.1016/j.cell.2017.12.019.
|
[11] |
van den Berg RA, Hoefsloot HC, Westerhuis JA, et al. Centering, scaling, and transformations: Improving the biological information content of metabolomics data. BMC Genomics, 2006, 7 142. DOI: 10.1186/1471-2164-7-142.
|
[12] |
Zhang J, Cao J, Zhang H, et al. Plasma copper and the risk of first stroke in hypertensive patients: A nested case-control study. Am J Clin Nutr, 2019, 110(1): 212-220. DOI: 10.1093/ajcn/ nqz099.
|
[13] |
王萌, 王如兴. ω-3多不饱和脂肪酸对糖尿病心血管的保护作用. 中华糖尿病杂志, 2013, 5(10): 638-640. DOI: 10.3760/cma. j.issn.1674-5809.2013.10.014.
|
[14] |
Tikhonenko M, Lydic TA, Opreanu M, et al. N-3 polyunsaturated Fatty acids prevent diabetic retinopathy by inhibition of retinal vascular damage and enhanced endothelial progenitor cell reparative function. PLoS One, 2013, 8(1): e55177. DOI: 10. 1371/journal.pone.0055177.
|
[15] |
马颀. 糖尿病视网膜病变的脂肪酸营养. 杭州: 浙江大学, 2015.
|
[16] |
Connor KM, SanGiovanni JP, Lofqvist C, et al. Increased dietary intake of omega-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis. Nat Med, 2007, 13(7): 868- 873. DOI: 10.1038/nm1591.
|
[17] |
Rodriguez Gonzalez-Herrero ME, Ruiz M, Lopez Roman FJ, et al. Supplementation with a highly concentrated docosahexaenoic acid plus xanthophyll carotenoid multivitamin in nonproliferative diabetic retinopathy: Prospective controlled study of macular function by fundus microperimetry. Clin Ophthalmol, 2018, 12: 1011-1020. DOI: 10.2147/OPTH.S157635.
|
[18] |
Hammes HP, Weiss A, Führer D, et al. Acceleration of experimental diabetic retinopathy in the rat by omega-3 fatty acids. Diabetologia, 1996, 122(1): 251-255. DOI: 10.1007/ BF00418338.
|
|
|
|